RAF1 and goblet cell carcinoma: Most mutations in genes constituting the RAS–RAF–MEK–ERK signaling pathway are reported in mucinous adenocarcinomas of the appendix (nine genes), followed by appendiceal goblet cell adenocarcinomas and well-differentiated neuroendocrine tumors of the appendix, with six genes each.